Nose spray for panic attacks?

March 5, 2012, Max-Planck-Gesellschaft
Individual nerve cells in the hippocampus have absorbed the Neuropeptide S, which was previously coloured with a red dye. The cell nucleii are blue and the axons are coloured green. Credit: Max Planck Institute of Psychiatry

(Medical Xpress) -- Max Planck researchers have succeeded in showing in experiments on mice that the anxiolytic substance neuropeptide S (NPS) can be absorbed through the nasal mucosa and unfold its effect in the brain. Having bound to its receptors, the neuropeptide S reaches particular neurons in the brain in this way. Just four hours after the administration of the drug, the tested mice showed less anxiety. Altered neuronal activity was also measured directly in the hippocampus, an important brain structure for learning and memory. These findings confirm that neuropeptide S is a promising new drug for the treatment of patients suffering from anxiety disorders.

Medications that the brain must overcome numerous hurdles, as it is a very difficult organ for drugs to access. For example, if a patient takes a pill, the drug must make its way through the , the liver and the blood-brain barrier. This often gives rise to undesired side effects. In addition, a lot of the necessary active substance is lost or it is altered in some way, or completely destroyed. The recently discovered anxiolytic neuropeptide S (NPS) would not be able to reach the brain in this manner. Treatment with this substance would only be conceivable by injection into the brain, a process that patients could not be expected to endure. Therefore, Ulrike Schmidt’s research group at the Max Planck Institute of Psychiatry examined, with the aid of mice, whether NPS could be absorbed into the brain through the nasal mucosa and take effect there.

In a series of sophisticated experiments, the scientists succeeded in visualising the path taken by intranasally administered NPS to special neurons in different regions of the brain. With this non-invasive method of administration, the targeted and highly specific absorption of the substance in the brain cells takes place through the binding of the substance to the NPS receptor. Just 30 minutes after administration through the nasal mucosa, small volumes of NPS had reached the mice brains. The anxiolytic effect unfolded four hours later: it could be observed that the mice had actually become less anxious. It was thus possible to demonstrate the anxiolytic effect of neuropeptide S when administered intranasally. The exact molecular mechanism of action of NPS is still unclear. However, as electrophysiological tests have shown, it clearly influences the signal transmission pathways between the neurons of the . The researchers suspect that NPS has an attenuating effect on certain signals of the brain’s emotion centre and less anxiety is perceived as a result.

“Our findings open the door to the development of new drugs based on neuropeptide S for patients suffering from pathological anxiety,” says psychiatrist Ulrike Schmidt. “The simple administration and the fast and successful effect of an anxiolytic nose spray could be a real blessing for many patients who suffer from like panic attacks and post-traumatic stress disorders.”

Explore further: Control of fear in the brain decoded

More information: Irina A Ionescu, et al. Intranasally Administered Neuropeptide S (NPS) Exerts Anxiolytic Effects Following Internalization into NPS Receptor-Expressing Neurons, Neuropsychopharmacology (2012), 1–15.

Related Stories

Control of fear in the brain decoded

September 6, 2011
When healthy people are faced with threatening situations, they react with a suitable behavioural response and do not descend into a state of either panic or indifference, as is the case, for example, with patients who suffer ...

Maternal care influences brain chemistry into adulthood

December 7, 2011
Neuropeptide Y (NPY) is the most abundant peptide hormone of the central nervous system. It is involved in various processes including stress management, the development of anxiety behaviour and body weight regulation. A ...

Recommended for you

Recording a thought's fleeting trip through the brain

January 17, 2018
University of California, Berkeley neuroscientists have tracked the progress of a thought through the brain, showing clearly how the prefrontal cortex at the front of the brain coordinates activity to help us act in response ...

Midbrain 'start neurons' control whether we walk or run

January 17, 2018
Locomotion comprises the most fundamental movements we perform. It is a complex sequence from initiating the first step, to stopping when we reach our goal. At the same time, locomotion is executed at different speeds to ...

Brain zaps may help curb tics of Tourette syndrome

January 16, 2018
Electric zaps can help rewire the brains of Tourette syndrome patients, effectively reducing their uncontrollable vocal and motor tics, a new study shows.

A 'touching sight': How babies' brains process touch builds foundations for learning

January 16, 2018
Touch is the first of the five senses to develop, yet scientists know far less about the baby's brain response to touch than to, say, the sight of mom's face, or the sound of her voice.

Researchers identify protein involved in cocaine addiction

January 16, 2018
Mount Sinai researchers have identified a protein produced by the immune system—granulocyte-colony stimulating factor (G-CSF)—that could be responsible for the development of cocaine addiction.

Neuroscientists suggest a model for how we gain volitional control of what we hold in our minds

January 16, 2018
Working memory is a sort of "mental sketchpad" that allows you to accomplish everyday tasks such as calling in your hungry family's takeout order and finding the bathroom you were just told "will be the third door on the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.